• Lun. Set 16th, 2024

Marketing Authorization

  • Home
  • TG SALUTEDOMANI TV: ARTIFICIAL INTELLIGENCE FALSE PREDICTIONS, PLITIDEPSIN REEVALUATION IN MULTIPLE MYELOMA

TG SALUTEDOMANI TV: ARTIFICIAL INTELLIGENCE FALSE PREDICTIONS, PLITIDEPSIN REEVALUATION IN MULTIPLE MYELOMA

WHEN TO TRUST AN ARTIFICIAL INTELLIGENCE AI MODEL Because machine-learning models can give false predictions, researchers often equip them with the ability to tell a user how confident they are…

Multiple Myeloma , Plitidepsin (Aplidin® PharmaMar) will be re-evaluated by the EMA

PharmaMar (MSE:PHM) has received a notification from the European Commission (EC) informing the Company of its decision to revoke the refusal to grant Marketing Authorization for plitidepsin (Aplidin®) in Multiple…